Michael Dear, PharmD

As the 10th anniversary of the FDA's public hearing on pregnancy labeling approached, the Teratology Society once again called for regulations to be enacted.

The American Thoracic Society (ATS) recently issued a statement on the hepatotoxicity of antituberculosis medications. The statement, which appeared in the Oct. 15 issue of the American Journal of Respiratory and Critical Care Medicine, addresses the growing incidence of drug-induced liver injury (DILI) by tuberculosis medications.